These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6129854)

  • 21. [The effect of memantine (dimethylamino-adamantane) on membranes of sensory nerve fibres (author's transl)].
    Grossmann W; Jurna I
    Arzneimittelforschung; 1977 Jul; 27(7):1483-7. PubMed ID: 578479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanism of action of amantadine in Parkinsonism: a review.
    Bailey EV; Stone TW
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):246-62. PubMed ID: 1180616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of ibopamine on central nervous system in mice and rats.
    Ferrini R; Miragoli G; Sala R; Reggiani A
    Arzneimittelforschung; 1986 Feb; 36(2A):327-30. PubMed ID: 3707643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of early lead exposure on neurotransmitter systems in the brain. A review with commentary.
    Shellenberger MK
    Neurotoxicology; 1984; 5(3):177-212. PubMed ID: 6151636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of 1,3-dimethyl-5-adamantanamine (D-145) on catecholaminergic neurons of the rat brain, Histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1976; 28(3):259-67. PubMed ID: 951308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].
    Haacke U; Sturm G; Süwer V; Wesemann W; Wildenhahn G
    Arzneimittelforschung; 1977 Jul; 27(7):1481-3. PubMed ID: 578478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of memantine on the anticonvulsant effects of the antiepileptic drugs.
    Chojnacka-Wójcik E; Tatarczyńska E; Maj J
    Pol J Pharmacol Pharm; 1983; 35(6):511-5. PubMed ID: 6429651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamine.
    Pycock CJ; Horton RW; Carter CJ
    Adv Biochem Psychopharmacol; 1978; 19():323-41. PubMed ID: 358783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.